FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve ...

Venetia Zachariou, PhD, Edward Avedisian Professor and chair of pharmacology, physiology & biophysics at Boston University Chobanian & Avedisian School of Medicine, has received a Distinguished ...

Opioid use disorder is associated with more than 350,000 deaths annually worldwide. Guided by the need for an increased understanding of critical neurobiological features of addiction, researchers ...

Opioid use disorder is associated with more than 350,000 deaths annually worldwide. Guided by the need for an increased ...

And Texas, spurred by a crusading longtime former governor, has the upper hand in bringing Ibogaine to the United States.

In simple terms, the Institute explained that the same nerve cells that make us feel full also trigger our cravings for sweets afterward. In fact, they noted that even the "mere perception" of having ...

VIP36, a new CB1 agonist, targets a cryptic pocket to provide analgesia for chronic pain while minimizing side effects and avoiding opioid-related risks.

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

"When mice are full and eat sugar, these nerve cells not only release signaling molecules that ... The team added that this specific opioid pathway was activated only when the mice ate additional ...